tiprankstipranks
The Fly

Nevro downgraded to Underweight from Equal Weight at Morgan Stanley

Nevro downgraded to Underweight from Equal Weight at Morgan Stanley

Morgan Stanley analyst Kallum Titchmarsh downgraded Nevro (NVRO) to Underweight from Equal Weight with a price target of $4, down from $9. Despite noting that the stock is trading around all-time lows, the firm expects spinal cord stimulation demand to remain soft and sees little room for cost cutting, the analyst tells investors.

Discover the Best Stocks and Maximize Your Portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1